Jeffrey W. Albers

SYRE

Jeffrey W. Albers serves as director at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

9 trades

$4.46M

Net Position

Net Seller

$4.46M

Companies Traded

SYRE, KYMR

Active Period

Jan 2024 – Aug 2026

9 total trades

Most Recent

Sell SYRE

Aug 10, 2026 · $2.40M

Jeffrey W. Albers's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

3 · $2.66M

Total Shares Bought

Total Shares Sold

30,000

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 10, 2026	Sell	23,000	$104.53	$2.40M	19,360
Nov 8, 2024	Sell	6,700	$36.76	$246.3K	27,360
Oct 28, 2024	Sell	300	$36.43	$10.9K	34,060

Jeffrey W. Albers's Insider Trading at Kymera Therapeutics, Inc. (KYMR)

Buys

0 · $0.00

Sells

6 · $1.80M

Total Shares Bought

Total Shares Sold

36,349

KYMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 8, 2025	Sell	5,000	$89.76	$448.8K	2,252
Oct 14, 2025	Sell	5,000	$59.19	$295.9K	0
Jun 3, 2025	Sell	6,349	$49.00	$311.1K	0
Aug 26, 2024	Sell	5,000	$49.10	$245.5K	0
Feb 21, 2024	Sell	5,000	$39.05	$195.3K	0
Jan 23, 2024	Sell	10,000	$30.05	$300.5K	0